More Physiologically-Relevant Cellular Assays for Cardio and Neurotoxicity Testing- An Interview With Susanne Bremer-Hoffmann
Pharma IQ:How are you developing more physiologically-relevant cellular assays for cardio and neurotoxicity testing?
Susanne Bremer-Hoffmann:In the last 3 years we have evaluated the potential of stem cells for cellular assays for cardio- and neurotoxicity testing in the framework of FP7 projects such as SCR&Tox and DETECTIVE in order to obtain standardized human cells in sufficient amounts to allow investigations of the mechanisms of toxicity. In the area of neurotoxicity, we have used...
To continue reading this story get free access